Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Injured in Motorcycle Crash on Highway 76 Near Vista Way


Motorcycle, Car Collide in Oceanside Accident

Any Type of Accident 20

Oceanside, CA (November 25, 2019) – A motorcyclist was injured in a crash in Oceanside. The accident occurred on the evening of November 25 on Highway 76.

A motorcycle and a car collided on Highway 76, near Vista Way. The cause of the crash is unknown. The motorcyclist was injured in the accident.

#Oceanside

#92058


November 26, 2019

Man Killed in Crash at Almaden Expressway and Canoas Garden Avenue

Victim Hit by Car in Fatal San Jose Accident...


April 3, 2020

Motorcyclist Injured in Crash on Highway 25

Motorcycle, Sedan Collided in King City Accident...


November 20, 2019

Amanda Dyball Injured in Pedestrian Crash on Highway 101

Victim Hit by Car in Eureka Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.